Literature DB >> 28944257

Affective Correlates of Psychosis in Parkinson's Disease.

Stewart A Factor1, Michael K Scullin2, Alan Freeman1, Donald L Bliwise1, William M McDonald3, Felicia C Goldstein1.   

Abstract

OBJECTIVE: To examine the nature of the association between affective disorders and psychosis in Parkinson's disease (PD).
BACKGROUND: In PD, psychosis and affective disorders are common and independently impact quality of life and mortality. Both depression and psychosis are correlated with the occurrence of cognitive dysfunction, suggesting that they may share neurobiological substrates. Anxiety has not been examined as a correlate of psychosis.
METHODS: 144 PD subjects were evaluated with the Schedule for Assessment of Positive Symptoms to assess psychotic features, while depression and anxiety were examined by the Structured Clinical Interview for DSM-IV-TR (SCID) and self-assessment scales Beck Depression Inventory II (BDI-II) and Beck Anxiety Inventory (BAI). Correlational analyses assessed associations between hallucinations and delusions with depression and anxiety.
RESULTS: A diagnosis of anxiety (SCID) was significantly (p=.015) associated with hallucinations (OR=4.81, CI=1.36-16.99). Severity of anxiety (BAI) significantly predicted (p=.03) the presence of hallucinations (OR=1.08, CI=1.01-1.15) and delusions (OR=1.09, CR=1.01-1.17). Current depression (SCID) was significantly (p=.001) associated with the presence of hallucinations (OR=6.12, CI=2.04-18.39) and delusions (OR=7.14, CI=2.23-22.93). Multiple linear regressions revealed that severity of anxiety remained an independent predictor (p<.05) of both the number of types of hallucinations (t=3.06, p=.003) and delusions (t=2.87, p=.005). Severity of depression was a significant predictor of the total number of delusions (t=2.28, p=.024).
CONCLUSIONS: This study demonstrates an association between depression and psychosis and, for the first time, an association between anxiety and psychosis. These associations may have implications on pathophysiology and treatment of psychosis in PD.

Entities:  

Keywords:  Anxiety; Delusions; Depression; Hallucinations; Parkinson’s disease

Year:  2016        PMID: 28944257      PMCID: PMC5608273          DOI: 10.1002/mdc3.12381

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  37 in total

1.  The DSM-IV Text Revision: rationale and potential impact on clinical practice.

Authors:  Michael B First; Harold Alan Pincus
Journal:  Psychiatr Serv       Date:  2002-03       Impact factor: 3.084

2.  What predicts mortality in Parkinson disease?: a prospective population-based long-term study.

Authors:  E B Forsaa; J P Larsen; T Wentzel-Larsen; G Alves
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

Review 3.  Parkinson's disease psychosis 2010: a review article.

Authors:  Joseph H Friedman
Journal:  Parkinsonism Relat Disord       Date:  2010-06-09       Impact factor: 4.891

4.  Risk factors for depression in Parkinson disease.

Authors:  E Tandberg; J P Larsen; D Aarsland; K Laake; J L Cummings
Journal:  Arch Neurol       Date:  1997-05

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Reliability and validity of the Beck depression inventory in patients with Parkinson's disease.

Authors:  Martine Visser; Albert F G Leentjens; Johan Marinus; Anne M Stiggelbout; Jacobus J van Hilten
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

7.  Cognitive correlates of hallucinations and delusions in Parkinson's disease.

Authors:  Stewart A Factor; Michael K Scullin; Ann B Sollinger; Julia O Land; Cathy Wood-Siverio; Lavezza Zanders; Alan Freeman; Donald L Bliwise; William M McDonald; Felicia C Goldstein
Journal:  J Neurol Sci       Date:  2014-10-23       Impact factor: 3.181

8.  Longitudinal outcome of Parkinson's disease patients with psychosis.

Authors:  S A Factor; P J Feustel; J H Friedman; C L Comella; C G Goetz; R Kurlan; M Parsa; R Pfeiffer
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

9.  Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume.

Authors:  Tom J van Mierlo; Chin Chung; Elisabeth M Foncke; Henk W Berendse; Odile A van den Heuvel
Journal:  Mov Disord       Date:  2015-01-20       Impact factor: 10.338

10.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

Authors:  Ian G McKeith
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

View more
  1 in total

1.  Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Authors:  Alberto J Espay; Michael T Guskey; James C Norton; Bruce Coate; Joaquin A Vizcarra; Clive Ballard; Stewart A Factor; Joseph H Friedman; Anthony E Lang; Niccole J Larsen; Candace Andersson; Doral Fredericks; Daniel Weintraub
Journal:  Mov Disord       Date:  2018-11-02       Impact factor: 10.338

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.